<DOC>
	<DOCNO>NCT03045627</DOCNO>
	<brief_summary>Most patient acute myeloid leukemia ( AML ) elder poor prognosis despite induction chemotherapy.The regimen cytarabine ( Ara-C ) , aclarubicin G-CSF ( CAG regimen ) widely use China treatment acute myeloid leukemia ( AML ) . Strategies reduce toxicity associate intensive chemotherapy include attenuate dos standard regimen myeloid growth factor . Granulocyte colony-stimulating factor ( G-CSF ) efective prophylaxis management chemotherapy-induced neutropenia，but require daily administration short half-life． Pegylated granulocyte colony-stimulating factor ( PEG-G-CSF ) long-acting reagent permit less frequent injection．The project undertaken Qilu Hospital Shandong University well-known hospital China.In order report efficacy safety PEG-G-CSF combine Ara-C aclarubicin treatment Acute Myeloid Leukemia , compare regimen Ara-C , aclarubicin G-CSF ( CAG ) .</brief_summary>
	<brief_title>Clinical Trial Ara-C , Aclarubicin Combined With PEG-G-CSF Initial Treatment AML Patients</brief_title>
	<detailed_description>The Investigators undertaking parallel , multicentre , randomise open-label trial newly diagnose AML ( APL ) patient China . Participants randomise select receive regimen Ara-C , aclarubicin PEG-G-CSF , regimen Ara-C , aclarubicin G-CSF ( CAG ) .Platelet count , bleed symptom evaluate treatment . Adverse event also record throughout study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Aclarubicin</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>1. age 60 year old , upper age limit 75 year ; 2. diagnosis AML APL 3 . Adequate hepatic renal function ( aspartate aminotransferase [ AST ] , alanine aminotransferase [ ALT ] , bilirubin creatinine &lt; 2.5 x upper normal limit ) . 1 . History severe congestive heart failure cardiac disease contraindicates use anthracyclines , include idarubicin 2 . Use recreational drug history drug addiction , within prior 6 month 3 . Known history positive hepatitis B surface antigens hepatitis C virus ( HCV ) antibodies 4 . Patients documented case human immunodeficiency virus ( HIV )</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Acute Myeloid Leukemia</keyword>
	<keyword>PEG-G-CSF</keyword>
</DOC>